Humby, F., Durez, P., Buch, M., Lewis, M., Bombardieri, M., John, C., . . . Pitzalis, C. (2022). Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: The R4-RA RCT. NIHR Journals Library.
Lua i Stíl Chicago (17ú heag.)Humby, F., et al. Rituximab Versus Tocilizumab and B-cell Status in TNF-alpha Inadequate-responder Rheumatoid Arthritis Patients: The R4-RA RCT. NIHR Journals Library, 2022.
Lua MLA (9ú heag.)Humby, F., et al. Rituximab Versus Tocilizumab and B-cell Status in TNF-alpha Inadequate-responder Rheumatoid Arthritis Patients: The R4-RA RCT. NIHR Journals Library, 2022.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.